<DOC>
	<DOCNO>NCT00656994</DOCNO>
	<brief_summary>The purpose study determine long-term effect Ramelteon , daily ( QD ) , endocrine function value .</brief_summary>
	<brief_title>Long-Term Efficacy Ramelteon Endocrine Function Adult Subjects With Chronic Insomnia</brief_title>
	<detailed_description>Insomnia characterize complaint either difficulty initiate maintain sleep nonrestorative non-refreshing sleep . Transient insomnia affect approximately one-third one-half US population , base result 2 survey representative sample adult US population conduct Gallup Organization respondent ask `` ever difficulty sleep . '' Based report `` regular '' `` frequent '' sleep difficulty , result study suggest approximately one-tenth US population experience chronic insomnia . The ideal treatment insomnia would reduce latency onset sleep increase total sleep time , without negative impact sleep architecture without safety concern next-day effect . Ramelteon melatonin-1 receptor agonist global development Takeda Chemical Industries , Ltd. , Osaka , Japan , treatment transient chronic insomnia treatment Circadian Rhythm Sleep Disorders . This study design determine long-term ( 6 month ) effect Ramelteon endocrine function value . Study participation anticipate 7 month .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Inclusion Criteria Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . Has primary insomnia define Diagnostic Statistical Manual Mental Disorders , Text Revision least 3 month history daytime complaint ( ) associate disturbed sleep . Has subjective sleep latency ( sSL ) great equal 45 minute subjective total sleep time le equal 6.5 hour least 3 night one week . Habitual bedtime 8:30PM 12:00AM . Habitual awakening time 5:00 AM 10:00 AM . Male female subject must serum prolactin , luteinizing hormone , follicle stimulate hormone , adrenocorticotropic hormone , thyroid stimulate hormone , triiodothyronine thyroxine within normal range . Normal range luteinizing hormone follicle stimulate hormone female subject define low value among menstrual phase high value among menstrual phase . Body mass index 18 34 , inclusive . Male subject must serum testosterone value great equal 150 ng per dL . Female subject must serum estradiol value within normal range . Exclusion Criteria Known hypersensitivity ramelteon related compound , include melatonin . Previously participate study involve ramelteon . Participated investigational study and/or take investigational drug within 30 day five halflives prior Day 1 , whichever longer . Sleep schedule change require employment ( eg , shift worker ) within three month prior Day 1 , fly across great three time zone within seven day prior screen . Participated weight loss program substantially alter exercise routine within 30 day prior Day 1 . Ever history seizure , sleep apnea , chronic obstructive pulmonary disease , restless leg syndrome , schizophrenia , bipolar disorder , mental retardation , cognitive disorder . History psychiatric disorder ( include anxiety depression ) within past 12 month . History drug addiction drug abuse within past 12 month . History alcohol abuse within past 12 month , define Diagnostic Statistical Manual Mental Disorders , Text Revision and/or regularly consumes 4 alcoholic drink per day . Current significant neurological ( include psychiatric cognitive disorder ) , hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , hematologic , metabolic disease , unless currently control stable protocolallowed medication 30 day prior Day 1 . Uses tobacco product nightly awakening . Used melatonin , drug supplement know affect sleep/wake function within 1week ( 5 half life drug , whichever long ) prior Day 1 . Used central nervous system medication within 1 week ( 5 half life drug , whichever long ) prior Day 1 . These medication must use treat psychiatric disorder . Any clinically important abnormal finding determine medical history , physical examination , electrocardiogram , clinical laboratory test , determine investigator . Positive hepatitis panel include anti hepatitis A virus ( immunoglobulin M exclusionary ) , anti hepatitis B surface ( except subject receive hepatitis B virus vaccination ) , hepatitis B surface antigen , antihepatitis B core ( immunoglobulin M exclusionary ) , antihepatitis C virus.. Any significant endocrine pathology base borderline laboratory result . Any additional condition ( ) Investigator 's opinion would : affect endocrine function ( eg , hyperthyroidism , diabetes ) prohibit subject completing study , best interest subject participate study . Morning serum cortisol Screening visit le 7.0 Î¼g per dl . Is required take continue take disallow medication , prescription medication , herbal treatment overthe counter medication may interfere evaluation study medication , include : anxiolytic hypnotic antidepressant anticonvulsant sedate H1 antihistamine systemic steroid respiratory stimulant ( eg , theophylline ) decongestant overthecounter prescription stimulant overthecounter prescription diet aids central nervous system active drug narcotic analgesic beta blocker St. John 's Wort kavakava gingko biloba melatonin drug supplement know affect sleep/wake function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Sleep Disorder</keyword>
	<keyword>Insomnia</keyword>
</DOC>